基于芬诺巴比他的酒精戒酒协议对提供者实践和患者结果的影响 - - 一项质量改善研究
Nicolette Centanni1, Taylor Mezoian1, John Gilboy1
1Maine Medical Center, Portland, ME, USA.
Hospital pharmacy
|September 27, 2024
概括
实行一种巴比他协议显著改变了酒精戒断综合征 (AWS) 治疗,增加了巴比他的使用,并降低了二胺剂量. 临床结果保持相似,趋势是住院时间缩短.
科学领域:
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
- 提高质量 提高质量
背景情况:
- 酒精戒断综合征 (AWS) 是一种常见的物质使用障碍,具有多样化的医疗管理.
- 二是AWS的标准一线治疗方法,但对于高风险患者来说,越来越多地考虑使用芬诺巴比他.
- 从历史上看,AWS在通用医疗服务上使用巴比他是有限的.
研究的目的:
- 评估AWS治疗的实践模式和临床结果,在实施基于巴比特的协议之前和之后.
- 评估新协议对使用巴比他和二zepines的影响.
- 检查与巴比他协议相关的安全结果.
主要方法:
- 对一般医学单位进行了一项质量改进研究.
- 这项研究比较了AWS管理之前和之后实施巴比他协议和电子医疗记录 (EMR) 订单集.
- 主要结局包括费诺巴比他加载剂量,同时使用二甲和总二甲剂量;安全结局也被评估.
主要成果:
- 法诺巴比他协议的实施增加了法诺巴比他加载剂量频率 (49.5%与9.4%相比),并降低了同时使用二西平 (4.3%与28.9%) 和总二西平剂量 (7.8毫克与15.5毫克相比).
- 没有观察到ICU转移率的显著差异.
- 在转移的患者中,发现了减少机械通风的趋势 (100%与28.6%) 和显著减少的ICU停留时间 (中位数为11天与3天). 在发作,妄想或辅助药物使用方面没有发现差异.
结论:
- 基于巴比特的机构协议的实施显著改变了AWS的提供者处方实践.
- 在协议实施后,没有观察到临床结果的整体差异.
- 需要进行进一步的研究来证实这些发现,并探讨在费诺巴比塔尔方案中观察到的急症监护室停留时间缩短.
相关概念视频
Sedatives and Hypnotics Drugs: Barbiturates
217
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
217
CNS Depressants: Barbiturates and Benzodiazepines
231
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
231
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
153
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
153
CNS Depressants: Alcohol and Nicotine
180
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
180
Depressants
104
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
104
Parenteral Anesthetics: Overview
111
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
111


